Rheumatoid arthritis can make life difficult for older adults who develop it later in life. This narrative review looks at a fresh angle: the connection between gut health and joint pain. It examines microbiota-targeted interventions, which include dietary changes, special supplements, and fecal microbiota transplantation. These approaches aim to shift the balance of bacteria in the digestive system. The review discusses these options as potential ways to support people dealing with this chronic condition. While the evidence comes from a narrative review rather than a large clinical trial, it highlights an area of growing interest. The authors note that more research is needed to confirm if these methods truly reduce inflammation or improve daily function. Safety data were not reported in this specific overview. This means we do not yet know if these interventions cause side effects in this population. The review serves as a starting point for conversation. It suggests that fixing gut health could be a useful addition to standard care. Patients and doctors should talk about these options before trying them. More rigorous studies are required to prove these benefits and ensure they are safe for everyone.
New review looks at gut health fixes for older adults with rheumatoid arthritis
Photo by National Cancer Institute / Unsplash
What this means for you:
A new review explores gut health changes for older adults with rheumatoid arthritis, though more research is needed. More on Rheumatoid Arthritis
CD38+ NK cells may link disrupted immune tolerance in rheumatoid arthritis and colorectal cancer Immune cells linked to cancer and arthritis show unusual activity in early review
Frontiers · May 29, 2026
Living systematic review finds low-certainty evidence that stopping csDMARDs before surgery may increase flare risk in inflammatory arthritis Stopping arthritis drugs before surgery may raise flare risk
Cochrane · May 20, 2026
Meta-analysis of upadacitinib for rheumatoid arthritis finds similar efficacy for 15 mg and 30 mg doses Upadacitinib improves rheumatoid arthritis symptoms in meta-analysis
Frontiers · May 20, 2026
Narrative review discusses CD40/CD40L signaling regulation in rheumatoid arthritis and other autoimmune conditions Safer CD40/CD40L targeting needs selectivity for autoimmune diseases
Frontiers · May 18, 2026